{"cursor":"11399","size":15,"audio":[],"currentlang":"en","article":"IDEC}} {{Infobox company\n| company_name = Biogen Idec, Inc. company_logo = company_type = Public\n| traded_as = NASDAQ-100 Component S&P 500 Component foundation = 2003\n| location = Weston, Massachusetts, U.S. key_people = William D. Young\n| (Chairman) George A. Scangos (CEO) industry =\n| Biotechnology products = Rituxan Avonex Tysabri revenue = US$ 5.048\n| billion (2011) operating_income = US$ 1.724\n| billion (2011) net_income = US$ 1.266 billion\n| (2011) assets = US$ 9.049 billion\n| (2011) equity = US$ 6.426 billion\n| (2011) num_employees = 4,850\n| (2010) homepage = [http://www.biogenidec.com/\n| BiogenIdec.com]\n}}\n\n'Biogen Idec, Inc.' is an American biotechnology company specializing in drugs\nfor neurological disorders, autoimmune disorders and cancer. The\ncompany was formed in 2003 by the merger of Cambridge, Massachusetts-based\nBiogen Inc. and San Diego, California-based IDEC Pharmaceuticals (formed in 1986\nby biotech pioneers Ivor Royston and Howard\nBirndorf). [http://www.sandiegometro.com/1999/apr/biotech.html \"Why San\nDiego Has Biotech\"], Fikes, Bradley J. San Diego Metropolitan, April 1999.\nAccessed June 20, 2008. Biogen, one of the oldest biotechnology companies,\nwas founded in 1978 in\nGeneva [http://www.biogenidec.ch/Our_History.aspx?ID=1957 \"Biogen\nHistory\"], by several biologists, including Kenneth Murray of the\nUniversity of Edinburgh, Phillip Sharp of the Massachusetts Institute of\nTechnology, Walter Gilbert of Harvard (who served as CEO during the start-up\nphase) and Charles Weissmann, University of Zurich (who contributed the first\nproduct interferon-alpha).\n\nBiogen Idec stock is a component of several stock indices such as the S&P 500,\nS&P 1500, and NASDAQ-100.\n","linknr":-1,"url":"Biogen","recorded":1376418385,"links":[],"instances":["engineer","biologist"],"pdf":[],"categories":["Companies in the NASDAQ Biotechnology Index","Companies based in Cambridge, Massachusetts","Biotechnology companies of the United States","National Medal of Technology recipients","Pharmaceutical companies of the United States","Companies established in 2003"],"headings":["Products","Locations of operation","Competitors","Management","Natalizumab withdrawal","Biogen Idec Foundation","References","External links"],"image":[],"tags":[["kenneth_murray","biologist"],["william_d._young","engineer"]],"members":["kenneth_murray"],"related":["Public_company","NASDAQ-100","S&P_500","Weston,_Massachusetts","Massachusetts","United_States","Chairman","Chief_Executive_Officer","Biotechnology","Rituxan","Avonex","Tysabri","United_States_dollar","Biotechnology","Neurology","Autoimmune_disorders","Cancer","Merger","Cambridge,_Massachusetts","San_Diego,_California","Ivor_Royston","Howard_Birndorf","Geneva","Kenneth_Murray_(biologist)","University_of_Edinburgh","Phillip_Sharp","Massachusetts_Institute_of_Technology","Walter_Gilbert","Harvard","Charles_Weissmann","University_of_Zurich","Interferon-alpha","S&P_500","S&P_1500","NASDAQ-100","Multiple_sclerosis","Avonex","Interferon_beta-1a","Tysabri","Natalizumab","Crohn's_disease","Élan","Rituxan","Rituximab","Non-Hodgkin's_lymphoma","Rheumatoid_arthritis","Genentech","Fumaderm","Fumaric_acid","Ester","Psoriasis","Zevalin","Ibritumomab_tiuxetan","Cell_Therapeutics","Bayer_Schering_Pharma","Amevive","Alefacept","Astellas_Pharma","Dimethyl_fumarate","Placebo","Weston,_Massachusetts","Research_and_development","Kendall_Square","Research_Triangle_Park,_North_Carolina","Hillerød","Denmark","Zug","Switzerland","Germany","France","Spain","Portugal","United_Kingdom","Ireland","Benelux","Sweden","Denmark","Norway","Finland","Austria","Canada","Japan","China","India","Australia","Italy","Switzerland","Teva_Pharmaceutical_Industries,_Ltd.","Sanofi_Aventis","Serono","Novartis","Bayer_Schering_Pharma","Multiple_sclerosis","Interferon_beta-1a","Genentech","Rituximab","Bruce_R._Ross","George_A._Scangos","Lawrence_C._Best","Marijn_E._Dekkers","Alan_B._Glassberg","Thomas_F._Keller","Nancy_L._Leaming","Robert_W._Pangia","Cecil_Pickett","Lynn_Schenk","Phillip_A._Sharp","William_D._Young_(engineer)","Carl_Icahn","Proxy_fight","Alexander_J._Denner","Anne_B._Young","Richard_C._Mulligan","ImClone_Systems","Élan","Natalizumab","Progressive_multifocal_leukoencephalopathy","Interferon_beta-1a","Crohns_disease"]}